Search Results Search Sort by RelevanceMost Recent Case and Commentary Nov 2019 In Experimental Hand Transplantation, Whose Views About Outcomes Should Matter Most? Andrea DiMartini, MD and Mary Amanda Dew, PhD Clinician-researchers deeply invested in data gathering are still obliged to respect a patient-subject’s right to stop being in research. AMA J Ethics. 2019;21(11):E936-942. doi: 10.1001/amajethics.2019.936. Case and Commentary Feb 2019 How Should Clinicians Communicate With Patients About the Roles of Artificially Intelligent Team Members? Daniel Schiff, MS and Jason Borenstein, PhD Clinical applications of AI prompt consideration of how responsibility should be distributed among professionals, tech companies, and others. AMA J Ethics. 2019;21(2):E138-145. doi: 10.1001/amajethics.2019.138. Podcast Nov 2019 Ethics Talk: Quality of Life Assessments in Reconstructive Transplantation Drs Katrina Bramstedt and Ana Iltis discuss the development of QoL assessment tools to help patient-subjects considering reconstructive transplantation. Medicine and Society Aug 2022 Clinicians’ Racial Biases as Pathways to Iatrogenic Harms for Black People Keisha Ray, PhD Clinicians’ racial biases undermine the quality of Black persons’ health care experiences and pave a reliable path to health care-induced harm. AMA J Ethics. 2022;24(8):E768-772. doi: 10.1001/amajethics.2022.768. Health Law Apr 2018 Plastic Surgery Overseas: How Much Should a Physician Risk in the Pursuit of Higher-Quality Continuity of Care? Scott Schweikart, JD, MBE Medical tourism creates an ethical dilemma for domestic physicians who wish to provide continuity of care but avoid liability in a malpractice suit. AMA J Ethics. 2018;20(4):357-365. doi: 10.1001/journalofethics.2018.20.4.hlaw1-1804. Case and Commentary Nov 2004 Clinical Trials and End-of-Life Decision Making, Commentary 1 David S. Alberts, MD Virtual Mentor. 2004;6(11):477-479. doi: 10.1001/virtualmentor.2004.6.11.ccas1-0411. Case and Commentary Nov 2004 Clinical Trials and End-of-Life Decision Making, Commentary 2 Lucy Godley, MD, PhD Virtual Mentor. 2004;6(11):479-481. doi: 10.1001/virtualmentor.2004.6.11.ccas1-0411. Viewpoint Feb 2016 Ethical Considerations of Transplantation and Living Donation for Patients with Alcoholic Liver Diseases Ajay Singhvi, MD, Alexandra N. Welch, Josh Levitsky, MD, Deepti Singhvi, MD, and Elisa J. Gordon, PhD, MPH Equal access is a goal even when patients present with taboo illnesses. But, the date of a patient’s last drink still matters. AMA J Ethics. 2016;18(2):163-173. doi: 10.1001/journalofethics.2017.18.2.sect1-1602. AMA Code Says Sep 2021 AMA Code of Medical Ethics’ Opinions Related to Implantable Devices Robert Dinallo The AMA Code of Medical Ethics offers guidance for balancing need for safety with demand for innovation. AMA J Ethics. 2021;23(9):E702-704. doi: 10.1001/amajethics.2021.702. Case and Commentary Nov 2020 Should a Good Risk Manager Worry About Cost and Price Transparency in Health Care? Josh Charles Hyatt, DHSc, MHL, MBE(c) and Stephen L. Newman, MD, MBA Once focused on hospital liability, risk managers now navigate a broader set of enterprise risk management responsibilities. AMA J Ethics. 2020;22(11):E924-932. doi: 10.1001/amajethics.2020.924. Pagination Current page 1 Page 2 Next page Next › Last page Last »
Case and Commentary Nov 2019 In Experimental Hand Transplantation, Whose Views About Outcomes Should Matter Most? Andrea DiMartini, MD and Mary Amanda Dew, PhD Clinician-researchers deeply invested in data gathering are still obliged to respect a patient-subject’s right to stop being in research. AMA J Ethics. 2019;21(11):E936-942. doi: 10.1001/amajethics.2019.936.
Case and Commentary Feb 2019 How Should Clinicians Communicate With Patients About the Roles of Artificially Intelligent Team Members? Daniel Schiff, MS and Jason Borenstein, PhD Clinical applications of AI prompt consideration of how responsibility should be distributed among professionals, tech companies, and others. AMA J Ethics. 2019;21(2):E138-145. doi: 10.1001/amajethics.2019.138.
Podcast Nov 2019 Ethics Talk: Quality of Life Assessments in Reconstructive Transplantation Drs Katrina Bramstedt and Ana Iltis discuss the development of QoL assessment tools to help patient-subjects considering reconstructive transplantation.
Medicine and Society Aug 2022 Clinicians’ Racial Biases as Pathways to Iatrogenic Harms for Black People Keisha Ray, PhD Clinicians’ racial biases undermine the quality of Black persons’ health care experiences and pave a reliable path to health care-induced harm. AMA J Ethics. 2022;24(8):E768-772. doi: 10.1001/amajethics.2022.768.
Health Law Apr 2018 Plastic Surgery Overseas: How Much Should a Physician Risk in the Pursuit of Higher-Quality Continuity of Care? Scott Schweikart, JD, MBE Medical tourism creates an ethical dilemma for domestic physicians who wish to provide continuity of care but avoid liability in a malpractice suit. AMA J Ethics. 2018;20(4):357-365. doi: 10.1001/journalofethics.2018.20.4.hlaw1-1804.
Case and Commentary Nov 2004 Clinical Trials and End-of-Life Decision Making, Commentary 1 David S. Alberts, MD Virtual Mentor. 2004;6(11):477-479. doi: 10.1001/virtualmentor.2004.6.11.ccas1-0411.
Case and Commentary Nov 2004 Clinical Trials and End-of-Life Decision Making, Commentary 2 Lucy Godley, MD, PhD Virtual Mentor. 2004;6(11):479-481. doi: 10.1001/virtualmentor.2004.6.11.ccas1-0411.
Viewpoint Feb 2016 Ethical Considerations of Transplantation and Living Donation for Patients with Alcoholic Liver Diseases Ajay Singhvi, MD, Alexandra N. Welch, Josh Levitsky, MD, Deepti Singhvi, MD, and Elisa J. Gordon, PhD, MPH Equal access is a goal even when patients present with taboo illnesses. But, the date of a patient’s last drink still matters. AMA J Ethics. 2016;18(2):163-173. doi: 10.1001/journalofethics.2017.18.2.sect1-1602.
AMA Code Says Sep 2021 AMA Code of Medical Ethics’ Opinions Related to Implantable Devices Robert Dinallo The AMA Code of Medical Ethics offers guidance for balancing need for safety with demand for innovation. AMA J Ethics. 2021;23(9):E702-704. doi: 10.1001/amajethics.2021.702.
Case and Commentary Nov 2020 Should a Good Risk Manager Worry About Cost and Price Transparency in Health Care? Josh Charles Hyatt, DHSc, MHL, MBE(c) and Stephen L. Newman, MD, MBA Once focused on hospital liability, risk managers now navigate a broader set of enterprise risk management responsibilities. AMA J Ethics. 2020;22(11):E924-932. doi: 10.1001/amajethics.2020.924.